secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOROX CO /DE/ (CLX)
CIK:        0000021076
Form:       8-K
Filed at:   2024-10-30T23:59:59+00:00
Accession:  0000021076-24-000038
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clorox Q1 FY2025: net sales +27% to $1.76B; adj. EPS $1.86 vs $0.49 YoY; raised outlook
--------------------------------------------------------------------------------

- Diluted EPS rose 371% to $0.80; adjusted EPS of $1.86 (+280% YoY) on strong ops and cyberattack lapping.
- Organic sales up 31%; volume growth 26% driven by Health & Wellness (+38%), Household (+43%), Lifestyle (+48%).
- Gross margin expanded 740 bps to 45.8% on higher volume and cost savings; FY2025 EPS and margin outlook raised.
- Year-to-date operating cash flow $221M vs $20M a year ago; free cash flow $182M vs -$4M.
- Better Health VMS divestiture completed Sep 10; one-time charge of $0.94/share in reported EPS.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/21076/000002107624000038/0000021076-24-000038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/21076/000002107624000038/clx-20241030.htm
  HTML page:      https://secwatch.observer/filing/0000021076-24-000038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer